ATTENTION NASDAQ: ZYXI INVESTORS: Contact Berger Montague About a Zynex Class Action Lawsuit
Portfolio Pulse from
Zynex (ZYXI) is facing a securities class action lawsuit alleging improper billing practices. A STAT report in June 2024 claimed the company was oversupplying medical device accessories to bill insurers excessively, leading to insurers removing them from networks. In March 2025, the company reported a significant revenue shortfall and revealed Tricare temporarily suspended payments, causing a 51% stock price drop.
April 09, 2025 | 12:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Zynex faces potential financial and legal challenges due to allegations of improper billing practices and payment suspensions, which significantly impacted its stock price and revenue.
The class action lawsuit and reported billing irregularities suggest significant legal and financial risks for Zynex. The 51% stock price drop reflects investor concerns about potential revenue loss, legal expenses, and reputational damage.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100